Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood.
about
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseDefining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigenMonoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activityThe effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis.Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodiesAn analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands.A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationResistance of Neisseria meningitidis to human serum depends on T and B cell stimulating protein B.Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding proteinEnhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisThe relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococciBinding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.Vaccines, reverse vaccinology, and bacterial pathogenesis.Gene variability and degree of expression of vaccine candidate factor H binding protein in clinical isolates of Neisseria meningitidis.Molecular characterization of two sub-family specific monoclonal antibodies to meningococcal Factor H binding protein.
P2860
Q26995760-5BECF366-2333-4E28-90CA-0B763473473BQ27676318-F9C5654C-AA67-44E0-BC77-6AE3718F4AC8Q28730934-A6092DFE-8D3A-4388-BD61-2FF4FFAA38C8Q34270429-C1636773-7BCE-4200-BED3-07CD14C71D9FQ34460783-DEB2C105-DE58-4173-A8A0-74E48D1FA38BQ34529441-39EC7CF7-1AE9-437F-B0FF-EF65E1B87AD8Q34746633-ECE28350-9E4E-43BA-A286-1DFB23925B10Q34993283-C13DC90C-680D-4BB6-B2D7-B6ED74C4AD69Q35187613-B57DD541-61AA-40B2-BECE-DBEC67F5039CQ35191862-9FA7FAA3-F9F5-46FF-A924-1BF8D41B8C6EQ35208975-0B6FE212-95D0-4193-AC04-CA9BBF0766DDQ35689526-F6CA9F63-0433-47E5-A5C7-EDF1AD008D10Q35936064-15E2B2EA-961C-4451-B922-FEAEB3EBA383Q35965207-4E4E3A66-96C8-407E-A7A5-6DCB0BA7703AQ36211092-71F7B08D-DCB3-407C-A364-6A34A3716316Q37002310-FF2C4A44-4E85-489F-BA51-BF8481DFB636Q37124721-5277D813-C8A8-45AF-99E6-3FAAC644442AQ37130358-87C3BE2F-41D0-41E1-A305-8108753B89D4Q37267074-B267F809-9065-4300-AF5E-67F19ACDB026Q39374965-F8E616C8-2AE7-4966-A415-99C12DC33526Q39426398-65DB71D6-EF8D-4DA9-B515-5C3AEB6A27D6Q45097394-4F95929B-AFC4-4A1E-848E-B2D2EC7673B7Q55266742-60CB6A1E-3E05-44E5-8221-8FF118747769
P2860
Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of factor H-binding pro ...... a meningitidis in human blood.
@ast
Effect of factor H-binding pro ...... a meningitidis in human blood.
@en
Effect of factor H-binding pro ...... a meningitidis in human blood.
@nl
type
label
Effect of factor H-binding pro ...... a meningitidis in human blood.
@ast
Effect of factor H-binding pro ...... a meningitidis in human blood.
@en
Effect of factor H-binding pro ...... a meningitidis in human blood.
@nl
prefLabel
Effect of factor H-binding pro ...... a meningitidis in human blood.
@ast
Effect of factor H-binding pro ...... a meningitidis in human blood.
@en
Effect of factor H-binding pro ...... a meningitidis in human blood.
@nl
P2093
P2860
P356
P1476
Effect of factor H-binding pro ...... a meningitidis in human blood.
@en
P2093
Barbara Brogioni
Dan M Granoff
Kathleen Y Dunphy
Peter T Beernink
P2860
P304
P356
10.1128/IAI.00849-10
P407
P577
2010-11-01T00:00:00Z